Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Lifespan Changes of the Human Brain In Alzheimer&apos, s Disease

  • Coupé, Pierrick
  • Lanuza, Enrique
  • Catheline, Gwenaelle
  • Manjón Herrera, José Vicente|||0000-0001-6640-927X
[EN] Brain imaging studies have shown that slow and progressive cerebral atrophy characterized the development of Alzheimer's Disease (AD). Despite a large number of studies dedicated to AD, key questions about the lifespan evolution of AD biomarkers remain open. When does the AD model diverge from the normal aging model? What is the lifespan trajectory of imaging biomarkers for AD? How do the trajectories of biomarkers in AD differ from normal aging? To answer these questions, we proposed an innovative way by inferring brain structure model across the entire lifespan using a massive number of MRI (N = 4329). We compared the normal model based on 2944 control subjects with the pathological model based on 3262 patients (AD + Mild cognitive Impaired subjects) older than 55 years and controls younger than 55 years. Our study provides evidences of early divergence of the AD models from the normal aging trajectory before 40 years for the hippocampus, followed by the lateral ventricles and the amygdala around 40 years. Moreover, our lifespan model reveals the evolution of these biomarkers and suggests close abnormality evolution for the hippocampus and the amygdala, whereas trajectory of ventricular enlargement appears to follow an inverted U-shape. Finally, our models indicate that medial temporal lobe atrophy and ventricular enlargement are two mid-life physiopathological events characterizing AD brain., This work benefited from the support of the project DeepVolBrain of the French National Research Agency (ANR-18-CE45-0013). This study was achieved within the context of the Laboratory of Excellence TRAIL ANR-10-LABX-57 for the BigDataBrain project. Moreover, we thank the Investments for the future Program IdEx Bordeaux (ANR-10-IDEX- 03-02, HL-MRI Project), Cluster of excellence CPU and the CNRS. This study has been also supported by the DPI2017-87743-R grant from the Spanish Ministerio de Economia, Industria y Competitividad. Moreover, this work is based on multiple samples. We wish to thank all investigators of these projects who collected these datasets and made them freely accessible. The C-MIND data used in the preparation of this article were obtained from the C-MIND Data Repository (accessed in Feb 2015) created by the C-MIND study of Normal Brain Development. This is a multisite, longitudinal study of typically developing children from ages newborn through young adulthood conducted by Cincinnati Children's Hospital Medical Center and UCLA and supported by the National Institute of Child Health and Human Development (Contract #s HHSN275200900018C). A listing of the participating sites and a complete listing of the study investigators can be found at https://research.cchmc.org/c-mind. The NDAR data used in the preparation of this manuscript were obtained from the NIH-supported National Database for Autism Research (NDAR). NDAR is a collaborative informatics system created by the National Institutes of Health to provide a national resource to support and accelerate research in autism. The NDAR dataset includes data from the NIH Pediatric MRI Data Repository created by the NIH MRI Study of Normal Brain Development. This is a multisite, longitudinal study of typically developing children from ages newborn through young adulthood conducted by the Brain Development Cooperative Group and supported by the National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke (Contract #s N01- HD02-3343, N01-MH9-0002, and N01-NS-9-2314, -2315, -2316, -2317, -2319 and -2320). A listing of the participating sites and a complete listing of the study investigators can be found at http://pediatricmri.nih.gov/nihpd/info/participating_centers.html. The ADNI data used in the preparation of this manuscript were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). The ADNI is funded by the National Institute on Aging and the National Institute of Biomedical Imaging and Bioengineering and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics NV, Johnson & Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche, Schering-Plough, Synarc Inc., as well as nonprofit partners, the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to the ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

volBrain: An Online MRI Brain Volumetry System

  • Manjón Herrera, José Vicente|||0000-0001-6640-927X
  • Coupé, Pierrick
The amount of medical image data produced in clinical and research settings is rapidly growing resulting in vast amount of data to analyze. Automatic and reliable quantitative analysis tools, including segmentation, allow to analyze brain development and to understand specific patterns of many neurological diseases. This field has recently experienced many advances with successful techniques based on non-linear warping and label fusion. In this work we present a novel and fully automatic pipeline for volumetric brain analysis based on multi-atlas label fusion technology that is able to provide accurate volumetric information at different levels of detail in a short time. This method is available through the volBrain online web interface (http://volbrain.upv.es), which is publically and freely accessible to the scientific community. Our new framework has been compared with current state-of-the-art methods showing very competitive results., We want to thank Sebastian Mouelboeck for his help to improve the robustness and reproducibility of the platform. We want also to thank Jose Enrique Romero Gomez and Elena Carrascosa for their help developing the volBrain web interface. This work benefited from the use of ITK-SNAP from the Insight Segmentation and Registration Toolkit (ITK) for 3D rendering. We also want to thank CBRAIN team (especially Marc Rousseau) for their help during experiments and for providing a really nice system to the community. This research was partially supported by the Spanish grant TIN2013-43457-R from the Ministerio de Economia y competitividad. This study has been also carried out with financial support from the French State, managed by the French National Research Agency (ANR) in the frame of the Investments for the future Programme IdEx Bordeaux (ANR-10-IDEX-03-02) by funding HL-MRI grant, Cluster of excellence CPU, LaBEX TRAIL (HR-DTI ANR-10-LABX-57), and the CNRS multidisciplinary project "Defi ImagIn." OASIS data used was collected thanks to grants: P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, and R01 MH56584. IXI data used was collected thanks to the grant EPSRC GR/S21533/02.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Hippocampal-amygdalo-ventricular atrophy score: Alzheimer disease detection using normative and pathological lifespan models

  • Coupé, Pierrick
  • Mansencal, Boris
  • Tourdias, Thomas
  • Catheline, Gwenaelle
  • Planche, Vincent
  • Manjón Herrera, José Vicente|||0000-0001-6640-927X
[EN] In this article, we present an innovative MRI-based method for Alzheimer disease (AD) detection and mild cognitive impairment (MCI) prognostic, using lifespan trajectories of brain structures. After a full screening of the most discriminant structures between AD and normal aging based on MRI volumetric analysis of 3,032 subjects, we propose a novel Hippocampal-Amygdalo-Ventricular Atrophy score (HAVAs) based on normative lifespan models and AD lifespan models. During a validation on three external datasets on 1,039 subjects, our approach showed very accurate detection (AUC >= 94%) of patients with AD compared to control subjects and accurate discrimination (AUC = 78%) between progressive MCI and stable MCI (during a 3-year follow-up). Compared to normative modeling, classical machine learning methods and recent state-of-the-art deep learning methods, our method demonstrated better classification performance. Moreover, HAVAs simplicity makes it fully understandable and thus well-suited for clinical practice or future pharmaceutical trials., UK Alzheimer's Society, Grant/Award Number: RF116; GlaxoSmithKline, Grant/Award Number: 6GKC; Leon Levy Foundation; NIMH, Grant/Award Numbers: R03MH096321, K23MH087770; ABIDE; U.K. Engineering and Physical Sciences Research Council, Grant/Award Number: GR/S21533/02; Canadian Institutes of Health Research, Grant/Award Number: MOP-34996; Human Brain Project, Grant/Award Number: PO1MHO52176-11; Alzheimer Drug Discovery Foundation; Alzheimer Association; National Health and Medical Research Council of Australia, Grant/Award Number: 1011689; Science Industry Endowment Fund; Common-wealth Scientific Industrial Research Organization; OASIS Brains Datasets, Grant/Award Numbers: P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584; NIH, Grant/Award Numbers: K01 AG030514, P30AG010129; National Institute of Biomedical Imaging and Bioengineering; National Institute on Aging; National Institutes of Health, Grant/Award Number: U01 AG024904; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institute on Drug Abuse; National Institute of Child Health and Human Development, Grant/Award Number: HHSN275200900018C; Ministerio de Ciencia e Innovacion, Grant/Award Number: PID2020-118608RB-I00; French National Research Agency, Grant/Award Number: ANR-18-CE45-0013
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Towards a Unified Analysis of Brain Maturation and Aging across the Entire Lifespan: A MRI Analysis

  • Coupé, Pierrick
  • Catheline, Gwenaelle
  • Lanuza, Enrique
  • Manjón Herrera, José Vicente|||0000-0001-6640-927X
[EN] There is no consensus in literature about lifespan brain maturation and senescence, mainly because previous lifespan studies have been performed on restricted age periods and/or with a limited number of scans, making results instable and their comparison very difficult. Moreover, the use of nonharmonized tools and different volumetric measurements lead to a great discrepancy in reported results. Thanks to the new paradigm of BigData sharing in neuroimaging and the last advances in image processing enabling to process baby as well as elderly scans with the same tool, new insights on brain maturation and aging can be obtained. This study presents brain volume trajectory over the entire lifespan using the largest age range to date (from few months of life to elderly) and one of the largest number of subjects (N=2,944). First, we found that white matter trajectory based on absolute and normalized volumes follows an inverted U-shape with a maturation peak around middle life. Second, we found that from 1 to 8-10 y there is an absolute gray matter (GM) increase related to body growth followed by a GM decrease. However, when normalized volumes were considered, GM continuously decreases all along the life. Finally, we found that this observation holds for almost all the considered subcortical structures except for amygdala which is rather stable and hippocampus which exhibits an inverted U-shape with a longer maturation period. By revealing the entire brain trajectory picture, a consensus can be drawn since most of the previously discussed discrepancies can be explained. Hum Brain Mapp 38:5501-5518, 2017. (C) 2017 Wiley Periodicals, Inc., French State (French National Research Ageny in the frame of the Investments for the future Program IdEx Bordeaux); Contract grant number: ANR-10-IDEX-03-02, HL-MRI Project; Contract grant sponsor: Cluster of excellence CPU and TRAIL (HR-DTI ANR-10-LABX-57); Contract grant sponsor: CNRS ("Defi imag'In and the dedicated volBrain support); Contract grant sponsor: Ministerio de Economia y competitividad (Spanish); Contract grant number: TIN2013-43457-R; Contract grant sponsor: National Institute of Child Health and Human Development; Contract grant number: HHSN275200900018C; Contract grant sponsors: National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke; Contract grant numbers: N01- HD02-3343, N01-MH9-0002, and N01-NS-9-2314, -2315, -2316, -2317, -2319 and -2320; Contract grant sponsor: National Institutes of Health; Contract grant number: U01 AG024904; Contract grant sponsor: National Institute on Aging and the National Institute of Biomedical Imaging and Bioengineering (ADNI); Contract grant sponsor: NIH; Contract grant number: P30AG010129, K01 AG030514; Contract grant sponsor: Dana Foundation; Contract grant sponsor: OASIS project (OASIS data); Contract grant numbers: P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584; Contract grant sponsor: Common-wealth Scientific Industrial Research Organization (a publicly funded government research organization); Contract grant sponsor: Science Industry Endowment Fund, National Health and Medical Research Council of Australia; Contract grant number: 1011689; Contract grant sponsors: Alzheimer's Association, Alzheimer's Drug Discovery Foundation, and an anonymous foundation; Contract grant sponsor: Human Brain Project; Contract grant number: PO1MHO52176-11 (ICBM, P.I. Dr John Mazziotta); Contract grant sponsor: Canadian Institutes of Health Research; Contract grant number: MOP-34996; Contract grant sponsor: U.K. Engineering and Physical Sciences Research Council (EPSRC); Contract grant number: GR/S21533/02; Contract grant sponsor: ABIDE funding resources; Contract grant sponsor: NIMH; Contract grant number: K23MH087770; Contract grant sponsor: Leon Levy Foundation; Contract grant sponsor: NIMH award to MPM; Contract grant number: R03MH096321
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

AssemblyNet: A large ensemble of CNNs for 3D whole brain MRI segmentation

  • Coupé, Pierrick
  • Mansencal, Boris
  • Clement, Michael
  • Giraud, Rémi
  • Denis de Senneville, Baudouin
  • Ta, Vinh-Thong
  • Lepetit, Vincent
  • Manjón Herrera, José Vicente|||0000-0001-6640-927X
[EN] Whole brain segmentation of fine-grained structures using deep learning (DL) is a very challenging task since the number of anatomical labels is very high compared to the number of available training images. To address this problem, previous DL methods proposed to use a single convolution neural network (CNN) or few independent CNNs. In this paper, we present a novel ensemble method based on a large number of CNNs processing different overlapping brain areas. Inspired by parliamentary decision-making systems, we propose a framework called AssemblyNet, made of two "assemblies" of U-Nets. Such a parliamentary system is capable of dealing with complex decisions, unseen problem and reaching a relevant consensus. AssemblyNet introduces sharing of knowledge among neighboring U-Nets, an "amendment" procedure made by the second assembly at higher-resolution to refine the decision taken by the first one, and a final decision obtained by majority voting. During our validation, AssemblyNet showed competitive performance compared to state-of-the-art methods such as U-Net, Joint label fusion and SLANT. Moreover, we investigated the scan-rescan consistency and the robustness to disease effects of our method. These experiences demonstrated the reliability of AssemblyNet. Finally, we showed the interest of using semi-supervised learning to improve the performance of our method., This work benefited from the support of the project DeepvolBrain of the French National Research Agency (ANR-18-CE45-0013). This study was achieved within the context of the Laboratory of Excellence TRAIL ANR-10-LABX-57 for the BigDataBrain project. Moreover, we thank the Investments for the future Program IdEx Bordeaux (ANR-10-IDEX-0 3-02, HL-MRI Project), Cluster of excellence CPU and the CNRS/INSERM for the DeepMultiBrain project. This study has been also supported by the DPI2017-87743-R grant from the Spanish Ministerio de Economia, Industria Competitividad. The C-MIND data used in the preparation of this article were obtained from the C-MIND Data Repository (accessed in Feb 2015) created by the C-MIND study of Normal Brain Development. This is a multisite, longitudinal study of typically developing children from ages newborn through young adulthood conducted by Cincinnati Children's Hospital Medical Center and UCLA and supported by the National Institute of Child Health and Human Development (Contract #s HHSN275200900018C). The NDAR data used in the preparation of this manuscript were obtained from the NIH-supported National Database for Autism Research (NDAR). This is a multisite, longitudinal study of typically developing children from ages newborn through young adulthood conducted by the Brain Development Cooperative Group and supported by the National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Neurological Disorders and Stroke (Contract #s N01- HD02-3343, N01-MH9-0002, and N01-NS-9-2314, -2315, -2316, -2317, -2319 and -2320). A listing of the participating sites and a complete listing of the study investigators can be found at http://pediatricmri.nih.gov/nihpd/info/participating_centers.html. The ADNI data used in the preparation of this manuscript were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI data are disseminated by the Laboratory for NeuroImaging at the University of California, Los Angeles. This research was also supported by NIH grants P30AG010129, K01 AG030514 and the Dana Foundation. The OASIS data used in the preparation of this manuscript were obtained from the OASIS project funded by grants P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584. The AIBL data used in the preparation of this manuscript were obtained from the AIBL study of ageing funded by the Common-wealth Scientific Industrial Research Organization (CSIRO; a publicly funded government research organization), Science Industry Endowment Fund, National Health and Medical Research Council of Australia (project grant 1011689), Alzheimer's Association, Alzheimer's Drug Discovery Foundation, and an anonymous foundation. The ICBM data used in the preparation of this manuscript were supported by Human Brain Project grant PO1MHO52176-11 (ICBM, P.I. Dr John Mazziotta) and Canadian Institutes of Health Research grant MOP-34996. The IXI data used in the preparation of this manuscript were supported by the U.K. Engineering and Physical Sciences Research Council (EPSRC) GR/S21533/02. ABIDE primary support for the work by Adriana Di Martino was provided by the NIMH (K23MH087770) and the Leon Levy Foundation. Primary support for the work by Michael P. Milham and the INDI team was provided by gifts from Joseph P. Healy and the Stavros Niarchos Foundation to the Child Mind Institute, as well as by an NIMH award to MPM (R03MH096321).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Non-local intracranial cavity extraction

  • Manjón Herrera, José Vicente|||0000-0001-6640-927X
  • Eskildsen, Simon F.
  • Coupé, Pierrick
  • Romero Gómez, José Enrique
  • Collins, Louis
  • Robles Viejo, Montserrat
[EN] Automatic and accurate methods to estimate normalized regional brain volumes from MRI data are valuable tools which may help to obtain an objective diagnosis and followup of many neurological diseases. To estimate such regional brain volumes, the intracranial cavity volume (ICV) is often used for normalization. However, the high variability of brain shape and size due to normal intersubject variability, normal changes occurring over the lifespan, and abnormal changes due to disease makes the ICV estimation problem challenging. In this paper, we present a new approach to perform ICV extraction based on the use of a library of prelabeled brain images to capture the large variability of brain shapes. To this end, an improved nonlocal label fusion scheme based on BEaST technique is proposed to increase the accuracy of the ICV estimation. The proposed method is compared with recent state-of-the-art methods and the results demonstrate an improved performance both in terms of accuracy and reproducibility while maintaining a reduced computational burden., The authors want to thank the IXI (EPSRC GR/S21533/02) and OASIS (P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, and R01 MH56584) dataset promoters for making available this valuable resource to the scientific community which surely will boost the research in brain imaging. This work has been supported by the Spanish Grant TIN2011-26727 from Ministerio de Ciencia e Innovacion. This work was funded in part by operating grants ´ from the Canadian Institutes of Health Research, les Fonds de la recherche sante du Quebec, MINDLab UNIK initiative at ´ Aarhus University, funded by the Danish Ministry of Science, Technology and Innovation, Grant agreement no. 09-065250.